Kabir Yadav1,2, Daniella Meeker3, Rakesh D Mistry4, Jason N Doctor3, Katherine E Fleming-Dutra5, Ross J Fleischman1, Samuel D Gaona6, Aubyn Stahmer7, Larissa May6. 1. Department of Emergency Medicine, Harbor-UCLA Medical Center, Torrance, CA. 2. Los Angeles Biomedical Research Institute, Torrance, CA. 3. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA. 4. Department of Pediatrics, Section of Emergency Medicine, Children's Hospital of Colorado, Aurora, CO. 5. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA. 6. Department of Emergency Medicine, University of California-Davis, Sacramento, CA. 7. Department of Psychiatry and Behavioral Sciences, University of California-Davis, Sacramento, CA.
Abstract
BACKGROUND: Antibiotics are commonly prescribed during emergency department (ED) and urgent care center (UCC) visits for viral acute respiratory infection (ARI). We evaluate the comparative effectiveness of an antibiotic stewardship intervention adapted for acute care ambulatory settings (adapted intervention) to a stewardship intervention that additionally incorporates behavioral nudges (enhanced intervention) in reducing inappropriate prescriptions. METHODS: This study was a pragmatic, cluster-randomized clinical trial conducted in three academic health systems comprising five adult and pediatric EDs and four UCCs. Randomization of the nine sites was stratified by health system; all providers at each site received either the adapted or the enhanced intervention. The main outcome was the proportion of antibiotic-inappropriate ARI diagnosis visits that received an outpatient antibiotic prescription by individual providers. We estimated a hierarchical mixed-effects logistic regression model comparing visits during the influenza season for 2016 to 2017 (baseline) and 2017 to 2018 (intervention). RESULTS: There were 44,820 ARI visits among 292 providers across all nine cluster sites. Antibiotic prescribing for ARI visits dropped from 6.2% (95% confidence interval [CI] = 4.5% to 7.9%) to 2.4% (95% CI = 1.3% to 3.4%) during the study period. We found a significant reduction in inappropriate prescribing after adjusting for health-system and provider-level effects from 2.2% (95% CI = 1.0% to 3.4%) to 1.5% (95% CI = 0.7% to 2.3%) with an odds ratio of 0.67 (95% CI = 0.54 to 0.82). Difference-in-differences between the two interventions was not significantly different. CONCLUSION: Implementation of antibiotic stewardship for ARI is feasible and effective in the ED and UCC settings. More intensive behavioral nudging methods were not more effective in high-performance settings.
RCT Entities:
BACKGROUND: Antibiotics are commonly prescribed during emergency department (ED) and urgent care center (UCC) visits for viral acute respiratory infection (ARI). We evaluate the comparative effectiveness of an antibiotic stewardship intervention adapted for acute care ambulatory settings (adapted intervention) to a stewardship intervention that additionally incorporates behavioral nudges (enhanced intervention) in reducing inappropriate prescriptions. METHODS: This study was a pragmatic, cluster-randomized clinical trial conducted in three academic health systems comprising five adult and pediatric EDs and four UCCs. Randomization of the nine sites was stratified by health system; all providers at each site received either the adapted or the enhanced intervention. The main outcome was the proportion of antibiotic-inappropriate ARI diagnosis visits that received an outpatient antibiotic prescription by individual providers. We estimated a hierarchical mixed-effects logistic regression model comparing visits during the influenza season for 2016 to 2017 (baseline) and 2017 to 2018 (intervention). RESULTS: There were 44,820 ARI visits among 292 providers across all nine cluster sites. Antibiotic prescribing for ARI visits dropped from 6.2% (95% confidence interval [CI] = 4.5% to 7.9%) to 2.4% (95% CI = 1.3% to 3.4%) during the study period. We found a significant reduction in inappropriate prescribing after adjusting for health-system and provider-level effects from 2.2% (95% CI = 1.0% to 3.4%) to 1.5% (95% CI = 0.7% to 2.3%) with an odds ratio of 0.67 (95% CI = 0.54 to 0.82). Difference-in-differences between the two interventions was not significantly different. CONCLUSION: Implementation of antibiotic stewardship for ARI is feasible and effective in the ED and UCC settings. More intensive behavioral nudging methods were not more effective in high-performance settings.
Authors: Steven L Bernstein; Edward Bernstein; Edwin D Boudreaux; Charlene Babcock-Irvin; Michael J Mello; Atul K Kapur; Bruce M Becker; Richard Sattin; Victor Cohen; Gail D'Onofrio Journal: Acad Emerg Med Date: 2007-08-15 Impact factor: 3.451
Authors: David Hürlimann; Andreas Limacher; Maria Schabel; Giorgio Zanetti; Christoph Berger; Kathrin Mühlemann; Andreas Kronenberg Journal: J Antimicrob Chemother Date: 2014-10-17 Impact factor: 5.790
Authors: Daniella Meeker; Jeffrey A Linder; Craig R Fox; Mark W Friedberg; Stephen D Persell; Noah J Goldstein; Tara K Knight; Joel W Hay; Jason N Doctor Journal: JAMA Date: 2016-02-09 Impact factor: 56.272
Authors: Katherine E Fleming-Dutra; Adam L Hersh; Daniel J Shapiro; Monina Bartoces; Eva A Enns; Thomas M File; Jonathan A Finkelstein; Jeffrey S Gerber; David Y Hyun; Jeffrey A Linder; Ruth Lynfield; David J Margolis; Larissa S May; Daniel Merenstein; Joshua P Metlay; Jason G Newland; Jay F Piccirillo; Rebecca M Roberts; Guillermo V Sanchez; Katie J Suda; Ann Thomas; Teri Moser Woo; Rachel M Zetts; Lauri A Hicks Journal: JAMA Date: 2016-05-03 Impact factor: 56.272
Authors: Stefan G Vanderweil; Chu-Lin Tsai; Andrea J Pelletier; Janice A Espinola; Ashley F Sullivan; David Blumenthal; Carlos A Camargo Journal: Acad Emerg Med Date: 2008-07-08 Impact factor: 3.451
Authors: Jeffrey S Gerber; Priya A Prasad; Alexander G Fiks; A Russell Localio; Robert W Grundmeier; Louis M Bell; Richard C Wasserman; Ron Keren; Theoklis E Zaoutis Journal: JAMA Date: 2013-06-12 Impact factor: 56.272
Authors: James M Chamberlain; Stephen J Teach; Katie L Hayes; Gia Badolato; Monika K Goyal Journal: Acad Emerg Med Date: 2016-01-14 Impact factor: 3.451
Authors: Lucila Ohno-Machado; Zia Agha; Douglas S Bell; Lisa Dahm; Michele E Day; Jason N Doctor; Davera Gabriel; Maninder K Kahlon; Katherine K Kim; Michael Hogarth; Michael E Matheny; Daniella Meeker; Jonathan R Nebeker Journal: J Am Med Inform Assoc Date: 2014-04-29 Impact factor: 4.497
Authors: Rachael L Fleurence; Lesley H Curtis; Robert M Califf; Richard Platt; Joe V Selby; Jeffrey S Brown Journal: J Am Med Inform Assoc Date: 2014-05-12 Impact factor: 4.497
Authors: Deanna J Buehrle; Rameez H Phulpoto; Marilyn M Wagener; Cornelius J Clancy; Brooke K Decker Journal: Antimicrob Agents Chemother Date: 2020-12-16 Impact factor: 5.191
Authors: Daniella Meeker; Paul Fu; Gary Garcia; Irene E Dyer; Kabir Yadav; Ross Fleishman; Hal F Yee Journal: J Am Med Inform Assoc Date: 2022-03-15 Impact factor: 4.497
Authors: Marina Zakharevich; Matthew A Kippenhan; Alice Lu; D Mark Courtney; Danielle M McCarthy; Howard S Kim Journal: J Am Coll Emerg Physicians Open Date: 2022-05-30
Authors: Edward Stenehjem; Anthony Wallin; Katherine E Fleming-Dutra; Whitney R Buckel; Valoree Stanfield; Kimberly D Brunisholz; Jeff Sorensen; Matthew H Samore; Raj Srivastava; Lauri A Hicks; Adam L Hersh Journal: Clin Infect Dis Date: 2020-04-10 Impact factor: 20.999
Authors: Daniel J Livorsi; Rajeshwari Nair; Andrew Dysangco; Andrea Aylward; Bruce Alexander; Matthew W Smith; Sammantha Kouba; Eli N Perencevich Journal: Open Forum Infect Dis Date: 2021-04-14 Impact factor: 4.423
Authors: Grace C Mortrude; Mary T Rehs; Katherine A Sherman; Nathan D Gundacker; Claire E Dysart Journal: Open Forum Infect Dis Date: 2021-12-11 Impact factor: 3.835
Authors: Usman Talat; Kelly Ann Schmidtke; Saval Khanal; Amy Chan; Alice Turner; Robert Horne; Tim Chadborn; Natalie Gold; Anna Sallis; Ivo Vlaev Journal: Front Pharmacol Date: 2022-01-25 Impact factor: 5.810